Skip to content

Clinical trials

Recurrence trials in Serbia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Recurrence Country / region: Serbia Clear all

19 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20051
20061
20073
20094
20111
20152
20172
20201
20211
20241
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Recruiting3
Active, not recruiting2
Terminated1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Biogen5
Kiniksa Pharmaceuticals International, plc2
AVEO Pharmaceuticals, Inc.1
AstraZeneca1
Daehwa Pharmaceutical Co., Ltd.1
Eli Lilly and Company1
Genzyme, a Sanofi Company1
Hoffmann-La Roche1
Karyopharm Therapeutics Inc1
Merck Sharp & Dohme LLC1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Recurrence19
Multiple Sclerosis7
Multiple Sclerosis, Relapsing-Remitting4
Leukemia2
Leukemia, Lymphocytic, Chronic, B-Cell2
Lymphoma2
Lymphoma, Large B-Cell, Diffuse2
Lymphoma, Non-Hodgkin2
Pericarditis2
Breast Neoplasms1

Trials

Showing 1 to 19 of 19. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.